Literature DB >> 17115110

Angiosarcoma of the breast: the experience of the European Institute of Oncology and a review of the literature.

Alberto Luini1, Giovanna Gatti, Jack Diaz, Edoardo Botteri, Eliegina Oliveira, Rafaela Cecilio Sahium de Almeida, Paolo Veronesi, Mattia Intra, Gianmatteo Pagani, Paola Naninato, Giuseppe Viale.   

Abstract

Angiosarcoma of the breast (AB) is a rare entity: its overall incidence is estimated at between 0.002% and 0.005% per year. Some potential risk factors have been described, mainly previous irradiation of the breast. We report the experience of the European Institute of Oncology with this unusual disease from January 1996 to January 2006: sixteen patients with angiosarcoma, 9 (56%) of whom had primary AB and 7 (44%), secondary AB, are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 17115110     DOI: 10.1007/s10549-006-9429-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  18 in total

1.  A Rare Case of Metachronous Bilateral Angiosarcoma of the Breast.

Authors:  Sheng-Ang Zhou; Hongquan Wei; Kefeng Ding
Journal:  Breast Care (Basel)       Date:  2009-12-15       Impact factor: 2.860

2.  Large clinical experience of primary angiosarcoma of the breast in a single Korean medical institute.

Authors:  Soo Youn Bae; Min-Young Choi; Dong Hui Cho; Jeong Eon Lee; Seok Jin Nam; Jung-Hyun Yang
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

Review 3.  Primary and secondary angiosarcoma of the breast.

Authors:  Tania K Arora; Krista P Terracina; John Soong; Michael O Idowu; Kazuaki Takabe
Journal:  Gland Surg       Date:  2014-02

Review 4.  Breast angiosarcoma that is not related to radiation exposure: a comprehensive review of the literature.

Authors:  Ioannis G Kaklamanos; Konstantinos Birbas; Konstantinos N Syrigos; Dimitrios Vlachodimitropoulos; Nikolaos Goutas; Gerassimos Bonatsos
Journal:  Surg Today       Date:  2011-01-26       Impact factor: 2.549

Review 5.  HIF-1α, VEGF and WT-1 are protagonists in bilateral primary angiosarcoma of breast: a case report and review of literature.

Authors:  Suhail Al-Salam; Nahed Balalaa; Issam Faour; Sayed Akhter; Mouied Alashari
Journal:  Int J Clin Exp Pathol       Date:  2012-03-25

6.  High-Grade Breast Epithelioid Angiosarcoma Secondary to Radiotherapy Metastasizing to the Contralateral Lymph Node: Unusual Presentation and Potential Pitfall.

Authors:  Ana Luísa Cunha; Isabel Amendoeira
Journal:  Breast Care (Basel)       Date:  2011-06-14       Impact factor: 2.860

7.  Primary angiosarcoma of the breast complicated by the syndrome of disseminated intravascular coagulation (DIC): Case report and literature review.

Authors:  Elena Alexandrova; Sonya Sergieva; Iglika Mihaylova; Antoaneta Zarkova
Journal:  Rep Pract Oncol Radiother       Date:  2013-12-08

8.  Breast Angiosarcoma: Case Series and Expression of Vascular Endothelial Growth Factor.

Authors:  Rondeep Brar; Robert West; Daniela Witten; Bhargav Raman; Charlotte Jacobs; Kristen Ganjoo
Journal:  Case Rep Oncol       Date:  2009-12-11

9.  Advanced breast angiosarcoma completely responding to gemcitabine-containing chemotherapy.

Authors:  Zhi-Guo Luo; Qian Wang; Wei Peng; Xi-Chun Hu; Xiao-Nan Hong
Journal:  Breast Care (Basel)       Date:  2012-10       Impact factor: 2.860

10.  Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis.

Authors:  Francisco Beca; Gregor Krings; Yunn-Yi Chen; Elizabeth M Hosfield; Poonam Vohra; Richard K Sibley; Megan L Troxell; Robert B West; Kimberly H Allison; Gregory R Bean
Journal:  Mod Pathol       Date:  2020-03-02       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.